GlassScriptPhysician profile
Frank Mcdermott
NPI 1053791426
$1,478.36
in general payments reported to CMS, 2019-2025
15 companies · $72.42 in 2025
The $72.42 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $405 · 2023: $656 · 2024: $345 · 2025: $72.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.79 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $468.32 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $279.24 | 2022-2024 | Ingrezza |
| Almatica Pharma LLC | $135.10 | 2023-2024 | Loreev Xr, Gralise |
| Otsuka America Pharmaceutical, INC. | $131.30 | 2022-2025 | Rexulti, Abilify Asimtufii |
| Takeda Pharmaceuticals U.S.A., INC. | $84.23 | 2022-2023 | Trintellix |
| Bausch Health US, LLC | $77.01 | 2022-2023 | Aplenzin, Wellbutrin |
| Orexo US, INC. | $72.86 | 2022-2025 | Zubsolv |
| E.R. Squibb & Sons, L.L.C. | $61.93 | 2024-2025 | Cobenfy |
| Indivior INC. | $45.10 | 2024 | Sublocade |
| Supernus Pharmaceuticals, INC. | $30.21 | 2023 | Qelbree |
| Boston Scientific Corporation | $25.29 | 2023 | |
| Corium, LLC | $18.69 | 2023 | Azstarys |
| Axsome Therapeutics, INC. | $17.99 | 2023 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.16 | 2023 | |
| Neos Therapeutics, LP | $13.93 | 2023 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Mcdermott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.